Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Miossec

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Annales De Dermatologie Et De Venereologie|January 1, 1982
[Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients]P Youinou, R Massé, P Peu-Duvallon, et al.
Therapie|November 7, 1998
[Cell adhesion molecules and pharmacologic applications. Round Table No 3 at Giens XIII]J McGregor, A Berdeaux, J Bonnet, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritisC Trocmé, H Marotte, A Baillet, et al.
The Journal of Clinical Investigation|June 23, 2000
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosionE Lubberts, L A Joosten, M Chabaud, et al.
Molecular Immunology|May 1, 1996
Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitorP Garrone, O Djossou, F Fossiez, et al.
The Journal of Rheumatology|August 26, 1998
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritisD Wendling, E Racadot, J Wijdenes, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodiesP Miossec, C L Verweij, L Klareskog, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Annales De Dermatologie Et De Venereologie|January 1, 1982
[Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients]P Youinou, R Massé, P Peu-Duvallon, et al.
Therapie|November 7, 1998
[Cell adhesion molecules and pharmacologic applications. Round Table No 3 at Giens XIII]J McGregor, A Berdeaux, J Bonnet, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritisC Trocmé, H Marotte, A Baillet, et al.
The Journal of Clinical Investigation|June 23, 2000
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosionE Lubberts, L A Joosten, M Chabaud, et al.
Molecular Immunology|May 1, 1996
Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitorP Garrone, O Djossou, F Fossiez, et al.
The Journal of Rheumatology|August 26, 1998
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritisD Wendling, E Racadot, J Wijdenes, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodiesP Miossec, C L Verweij, L Klareskog, et al.
Pageof 18